Emami, Global Health stocks jump over 5%, among top gainers on Nifty Midcap 150

Disclaimer This is an AI-assisted live blog with updates from multiple sources Disclaimer

In Wednesday's session, several stocks demonstrated notable gains, positioning them as top performers within the Nifty Midcap 150 index. At 3.00 pm, Emami led the pack with a 5.53% increase, reaching Rs 605.30, followed by Global Health, which rose by 5.33% to Rs 1,283.00. FSN E-Co Nykaa also showed strong performance, gaining 4.4% to reach Rs 211.51, while Mankind Pharma and Coromandel International recorded gains of 3.83% and 3.76%, trading at Rs 2,524.90 and Rs 2,290.50, respectively.

Emami Financial Highlights

Emami's financial performance, as per its standalone income statement, reveals the following trends:

The sales for Emami decreased from Rs 1,993 Crore in March 2024 to Rs 1,928 Crore in March 2025. The net profit also saw a decrease from Rs 84 Crore in March 2024 to Rs 26 Crore in March 2025.

Emami's quarterly financials present the following data:

Emami's quarterly sales decreased from Rs 484 Crore in March 2024 to Rs 474 Crore in March 2025. Similarly, the net profit declined from Rs 27 Crore in March 2024 to Rs 3 Crore in March 2025.

Global Health Financials

Global Health's consolidated yearly financial data shows consistent growth.

The revenue increased steadily from Rs 2,166.59 Crore in 2022 to Rs 3,692.32 Crore in 2025. Net profit also saw a significant rise from Rs 196.20 Crore in 2022 to Rs 481.32 Crore in 2025. The company's Debt to Equity ratio has decreased from 0.52 in 2022 to 0.10 in 2025.

FSN E-Commerce Ventures, which operates Nykaa, also showed positive consolidated yearly financial results:

Revenue increased from Rs 2,440.90 Crore in 2021 to Rs 7,949.82 Crore in 2025. Net profit also increased from Rs 61.95 Crore in 2021 to Rs 73.70 Crore in 2025.

Mankind Pharma's consolidated yearly financials show consistent growth:

Revenue has steadily increased from Rs 6,214.43 Crore in 2021 to Rs 12,207.44 Crore in 2025. Net profit has also increased from Rs 1,281.36 Crore in 2021 to Rs 1,998.88 Crore in 2025.

Corporate Actions

Emami:

• On July 8, 2025, Emami announced compliance with SEBI regulations concerning depositories and participants for the period from April 1, 2025, to June 30, 2025.
• The company's board will meet on July 29, 2025, to consider and approve the unaudited financial results for the quarter ended June 30, 2025.

Emami has announced dividends with the following details:

• Final Dividend: Rs 1.60 per share (80%) announced on May 28, 2024, with an effective date of August 21, 2024.

Global Health:

• On June 27, 2025, Global Health announced the closure of the trading window from July 1, 2025, until 48 hours after the dissemination of unaudited financial results for the quarter ended June 30, 2025.

Global Health announced a final dividend of Rs 0.50 per share (25%) on May 15, 2025.

FSN E-Co Nykaa:

• On July 6, 2025, FSN E-Co Nykaa provided a quarterly revenue update for Q1 FY2026.

Coromandel International:

• Coromandel International announced dividend with following details:
• A final dividend of Rs 6.00 per share (600%) and special dividend of Rs 3.00 per share (300%) was announced on May 1, 2025, with effective date as July 17, 2025.

These stocks demonstrated significant upward movement, making them top gainers in today's trading session on the Nifty Midcap 150.